|
|
| www.cardiovascmed.ch |
|
|
|
|
Haouala A, Widmer N, Montemurro M, Buclin T, Decosterd L. Cardiovascular drug interactions with tyrosine kinase inhibitors [147] |
|
|
|
|
|
Fassa AA, Urban P, Radovanovic D, Eberli F, Polikar R, Stauffer J-C, Bertel O, Erne P. Impact of comorbidities on clinical presentation, management and outcome of patients with acute coronary syndrome [155] |
|
|
Stoira E, Capoferri M, Molteni A, Bachmann LM, Moccetti T. Effects of the implementation of a multidisciplinary cardiac rehabilitation programme in clinical practice [162] |
|
|
Aragão A, Vogel D, Schmidt C. Muscular ventricular septal defect after mitral and aortic valve replacement [167] |
|
|
|
|
|
Pilgrim T, Wenaweser P, Windecker S, Meier B. Comprehensive "one stop-shop" percutaneous cardiac intervention [171] |
|
|
|
|
|
Schneiter S, Taylor AJ. Intramyocardial haemorrhage [174] |
|
|
|
|
|
Research Prize of the Swiss Heart Foundation [176] |
|
|
Zwicky P, Burri H, Schär B, Schwick N, Bauersfeld U, Babotai I, Fuhrer J, Gloor HO, Schläpfer J, Sticherling C. Checkliste für das perioperative Management von Schrittmacher- und ICD-Patienten [177] |
|
|
| |
|
Copyright © 2010 EMH Swiss Medical Publishers Ltd. |